Equities

NDT Pharmaceuticals Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
NDTP:PKC

NDT Pharmaceuticals Inc

Actions
  • Price (USD)0.95
  • Today's Change0.000 / 0.00%
  • Shares traded4.69k
  • 1 Year change+1,280.81%
  • Beta--
Data delayed at least 15 minutes, as of Feb 09 2026 20:47 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

NDT Pharmaceuticals, Inc. is a Canada-based company, which is focused on developing nutraceutical and pharmaceutical products utilizing intellectual property. The Company has acquired all rights under a Sponsored Research Agreement with the University of Pennsylvania, including rights to use the University's Nanoscale Particle Complex (NPC) technology. The intellectual property includes an applicable biotechnology asset base, including the Nanoscale Particle Complex (NPC) technology, which represents phospholipid-based nano-encapsulation delivery systems that create instant delivery of payloads into the bloodstream, beginning through the membranes of the mouth. Encapsulated actives are protected from destruction in the highly acidic environment of the stomach until they reach the small intestine. The NPC technology also incorporates a potent active ingredient that stimulates the repair of damaged cell tissue branded by the Company as Cell Armor.

  • Revenue in USD (TTM)--
  • Net income in USD--
  • Incorporated2005
  • Employees1.00
  • Location
    NDT Pharmaceuticals IncSuite 809-4438 West 10Th AvenueVANCOUVER V6R 4R8CanadaCAN
  • Phone+1 (604) 689-4088
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Assertio Holdings Inc137.35m-28.92m77.13m58.00--0.72934.950.5616-4.71-4.7120.9316.490.46111.351.472,368,138.00-9.71-15.74-17.07-24.1968.1682.29-21.06-42.011.43--0.2702---17.83-11.4593.50------
NovaBay Pharmaceuticals Inc2.83m-7.95m93.03m14.00------32.87-1.580.53770.5550.27180.7686--5.28202,142.90-215.92-61.58-404.37-83.7954.5659.49-280.92-77.39---91.560.0836---33.588.1948.52---20.59--
Alpha Cognition Inc7.43m-19.47m106.97m52.00--2.36--14.40-1.37-1.370.50022.090.2894--5.22142,830.80-75.87-119.10-93.86-159.0573.09---262.18--6.03-7.910.00-------6.34------
Verrica Pharmaceuticals Inc30.83m-26.01m110.49m71.00------3.58-3.44-3.443.50-1.800.83521.098.75434,211.30-70.48-71.91-217.79-111.9191.36---84.38-729.001.18-1.701.94--47.66---14.31---47.58--
Biostem Technologies Inc235.17m20.20m113.12m67.007.472.265.540.4810.90190.901911.602.982.822.614.65--24.25--55.07--97.33--8.59--4.09--0.0566--1,708.93--475.86------
Fortress Biotech Inc62.30m-5.34m113.60m101.00--2.03--1.82-0.293-0.2932.161.800.40391.504.35616,861.40-34.90-54.95-51.59-102.1371.5662.39-86.41-227.711.97-10.630.4503---31.769.5018.61--25.88--
Karyopharm Therapeutics Inc142.53m-124.62m115.54m279.00------0.8106-14.58-14.5816.69-30.940.99771.344.48510,860.20-87.24-48.75-181.85-63.6495.9397.09-87.43-92.030.9842-2.55-----0.545128.8546.60---7.17--
Whitehawk Therapeutics Inc14.38m-15.62m131.02m22.0020.470.8336--9.110.13580.13580.28023.330.11380.56694.40359,600.00-12.36-52.97-13.76-60.6389.22---108.58-372.6716.76--0.00--6.69--3.15--47.49--
NDT Pharmaceuticals Inc-100.00bn-100.00bn152.00m1.00--0.8486----------1.12-----------164.47---452.47-------6,891.36----0.00---100.00--87.56------
BGM Group Ltd26.85m-2.72m175.45m323.00--0.5829--6.54-0.2816-0.28161.381.850.20873.218.6083,116.91-2.08-0.0792-2.36-0.106519.4110.38-9.95-0.09211.45-0.34080.00872,560.18-45.99-11.4581.46--16.40--
Sanara Medtech Inc101.90m-6.24m178.00m141.00--28.93--1.75-0.7292-4.3411.860.68851.282.478.78722,724.30-8.03-15.12-10.00-18.6492.2588.92-6.29-14.701.600.30390.8801--33.3649.09-124.59---33.05--
Tonix Pharmaceuticals Holding Corp10.30m-99.22m207.90m81.00--0.7149--20.19-20.11-20.111.6922.730.05930.96652.75127,148.10-57.12-61.84-63.76-68.6734.31---963.38-2,797.359.62--0.00--29.94---11.47--47.82--
Journey Medical Corp59.40m-8.66m219.14m41.00--8.19--3.69-0.3645-0.36452.580.9820.7961.794.151,448,756.00-11.61-22.37-22.74-50.5564.4059.45-14.58-27.431.12-3.300.4928---29.119.96-280.79--44.27--
Data as of Feb 09 2026. Currency figures normalised to NDT Pharmaceuticals Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.